GlassScriptPhysician profile
Maurice Darvish
NPI 1568572618
$651.68
in general payments reported to CMS, 2019-2025
10 companies · $190 in 2025
The $190 reported for 2025 was more than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $120 · 2020: $18.10 · 2021: $140 · 2022: $52.73 · 2023: $47.47 · 2024: $83.75 · 2025: $190.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $321.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $320.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Viiv Healthcare Company | $165.33 | 2022-2025 | Apretude |
| Astrazeneca Pharmaceuticals LP | $133.14 | 2024-2025 | Breztri |
| Gilead Sciences, INC. | $119.85 | 2019 | |
| Abbvie INC. | $108.08 | 2021-2022 | |
| Genentech USA, INC. | $25.00 | 2021 | |
| Hologic Sales and Service, LLC | $24.72 | 2023 | Aptima |
| Medline Industries LP | $22.75 | 2023 | |
| Glaxosmithkline, LLC. | $19.37 | 2021 | |
| Nabriva Therapeutics, Plc | $18.10 | 2020 | |
| Merz North America, INC. | $15.34 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Maurice Darvish listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.